INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

WELLINGTON MANAGEMENT GROUP LLP's Holding History (CIK: 0000902219)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 190,370 Value ($000) $25,114 Avg Close Range
Q4 2024
Shares 1,033,743 Value ($000) $86,338 Avg Close Range
Q3 2024
Shares 1,017,647 Value ($000) $74,461 Avg Close Range
Q2 2024
Shares 1,252,904 Value ($000) $85,811 Avg Close Range
Q1 2024
Shares 1,661,870 Value ($000) $115,001 Avg Close Range
Q4 2023
Shares 1,763,475 Value ($000) $126,300 Avg Close Range
Q3 2023
Shares 1,815,954 Value ($000) $94,593 Avg Close Range
Q2 2023
Shares 1,701,584 Value ($000) $107,744 Avg Close Range
Q1 2023
Shares 5,024,783 Value ($000) $272,092 Avg Close Range
Q4 2022
Shares 5,409,685 Value ($000) $286,281 Avg Close Range
Q3 2022
Shares 5,158,750 Value ($000) $240,037 Avg Close Range
Q2 2022
Shares 4,463,358 Value ($000) $254,767 Avg Close Range
Q1 2022
Shares 4,061,160 Value ($000) $248,502 Avg Close Range